BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4145866)

  • 21. A clinical study with propericiazine in chronic psychotic patients.
    Deutsch M; Ananth JV; Ban TA
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):353-8. PubMed ID: 4397391
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of butaperazine in chronic schizophrenia.
    Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR
    Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical evaluation of butaperazine.
    Feldman PE
    Psychosomatics; 1967; 8(1):26-8. PubMed ID: 4382889
    [No Abstract]   [Full Text] [Related]  

  • 24. Liquid butaperazine in the treatment of chronic psychosis in a mental health clinic.
    Clare G; Simeon J; Fink M
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):57-63. PubMed ID: 4388407
    [No Abstract]   [Full Text] [Related]  

  • 25. Uncontrolled study with pipothiazine palmitate.
    Jain RC; Ananth JV; Klingner A; Ban TA; Lehmann HE
    Int J Clin Pharmacol; 1973 Feb; 7(1):32-6. PubMed ID: 4699381
    [No Abstract]   [Full Text] [Related]  

  • 26. Butaperazine and prochlorperazine; a comparative trial of two phenothiazines.
    Bordeleau JM; Rajotte P; Tétreault L
    Chemotherapia (Basel); 1964-1965; 9(4):248-58. PubMed ID: 4378567
    [No Abstract]   [Full Text] [Related]  

  • 27. Prediction of response to phenothiazines in schizophrenia. A crossvalidation study.
    Goldberg SC; Frosch WA; Drossman AK; Schooler NR; Johnson GF
    Arch Gen Psychiatry; 1972 Apr; 26(4):367-73. PubMed ID: 4552130
    [No Abstract]   [Full Text] [Related]  

  • 28. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of dosage ranges of carphenazine and trifluoperazine in elderly chronic schizophrenics.
    Bora G
    Dis Nerv Syst; 1968 Oct; 29(10):695-7. PubMed ID: 4887393
    [No Abstract]   [Full Text] [Related]  

  • 30. Reappraisal of nurse's role in the treatment of schizophrenia.
    Kelleher MJ
    Int J Nurs Stud; 1974 Dec; 11(4):197-202. PubMed ID: 4497842
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experiences with thiothixene (navane) in chronic schizophrenia].
    Gann G
    Wien Med Wochenschr; 1968 Jan; 118(1):10-3. PubMed ID: 5668801
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions.
    Garver DL; Davis JM; Dekirmenjian H; Jones FD; Casper R; Haraszti J
    Arch Gen Psychiatry; 1976 Jul; 33(7):862-6. PubMed ID: 8025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quide vs. Mellaril in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):10-6. PubMed ID: 4621558
    [No Abstract]   [Full Text] [Related]  

  • 34. Lack of effect of a gluten-free diet on neuroleptic blood levels in schizophrenic patients.
    Osborne M; Crayton JW; Javaid J; Davis JM
    Biol Psychiatry; 1982 May; 17(5):627-9. PubMed ID: 6124283
    [No Abstract]   [Full Text] [Related]  

  • 35. Problems in the evaluation of the optimal dose of a phenothiazine (butaperazine).
    Simpson GM; Amin M; Kunz-Bartholini E; Watts TP; Laska E
    Dis Nerv Syst; 1968 Jul; 29(7):478-84. PubMed ID: 4386374
    [No Abstract]   [Full Text] [Related]  

  • 36. Indications for high dose chlorpromazine therapy in chronic schizophrenia.
    Prien RF; Levine J; Cole JO
    Dis Nerv Syst; 1970 Nov; 31(11):739-45. PubMed ID: 4923151
    [No Abstract]   [Full Text] [Related]  

  • 37. Schizophrenics: the efficacy of phenothiazines.
    McNamee HB
    Am J Psychiatry; 1971 Nov; 128(5):657. PubMed ID: 5114388
    [No Abstract]   [Full Text] [Related]  

  • 38. Pipotiazine palmitate: an evaluation of a new long acting intramuscular antipsychotic agent in severely ill schizophrenic patients.
    Gallant DM; Mielke D; Bishop G; Oelsner T; Guerrero-Figueroa R
    Dis Nerv Syst; 1975 Apr; 36(4):193-6. PubMed ID: 1090427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A versatile new sustained-action neuroleptic: pipotiazine palmitate in psychiatric practice.
    Johnston RE; Niesink F
    J Int Med Res; 1979; 7(3):187-93. PubMed ID: 37133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of butaperazine and prochlorperazine for schizophrenia in acute phase].
    Albert JM; Rajotte P; Rajotte E; Tétreault L
    Union Med Can; 1970 Jul; 99(7):1282-5. PubMed ID: 4396306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.